SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Cipla’s arm completes allocation of shares to FIL Capital Investments

13 Apr 2016 Evaluate

Cipla’s subsidiary -- Cipla Health has allotted shares to FIL Capital Investments (Mauritius) II and consequently, the transaction has now been completed. The company’s board at its meeting held on April 12, 2016, has approved for the same.

Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 150 countries. Its portfolio includes 1500 plus products across therapeutic categories with one quality standard globally.

Cipla Share Price

1232.55 -5.75 (-0.46%)
20-Apr-2026 14:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.20
Dr. Reddys Lab 1233.60
Cipla 1232.55
Zydus Lifesciences 937.30
Lupin 2326.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×